Cervical Erector Spinae Plane Block vs Cervical Plexus Block in Controlling Acute Postoperative Pain After Thyroidectomy

Cairo University (CU)

Status: Completed

Conditions: Postoperative Pain; Erector Spinae Plane Block; Cervical; Thyroidectomy; Cervical Plexus Block

Treatments: Other: Cervical erector spinae plane block; Other: Cervical plexus block

Study type: Interventional

Funder types: Other

Identifiers

NCT06974630

AP2411-501-102-193

Details and patient eligibility

About

This study aims to compare the efficacy and safety of cervical erector spinae plane block vs. cervical plexus block in controlling acute postoperative pain after thyroidectomy.

Full description

Thyroidectomy is one of the most commonly performed surgeries in females worldwide, as thyroid disease predominantly affects females with a ratio of 4:1. Thyroid operations can cause mild to moderate incisional pain. It has also been reported that the morphine consumption on the first postoperative day is 90%.

Cervical plexus block, either superficial or deep or combinations given bilaterally, could easily lead to an adequate block appropriate for thyroid surgery without any significant side effects.

Erector spinae plane block (ESPB) is the new favorite among various fascial plane blocks. Local anesthetic drug is injected in the fascial plane superficial to the transverse process and deeper to the erector spinae muscle (ESM).

Enrollment: 40 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age from 18 to 65 years.
• Both genders.
• American Society of Anesthesiologists (ASA) physical status I-II.
• Scheduled for either hemi- or total thyroidectomy.

Exclusion criteria

• Known allergy to local anesthetics.
• Allergy to all opioid medications.
• Pregnant patient.
• Previous neck surgery.
• Recent use of non-steroidal anti-inflammatory drugs (NSAIDs), opioids or steroid injection within 2 weeks.
• Those who cannot utilize the numeric rating scale (NRS) .
• Chronic opioid use.
• Coagulopathy.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

ESPB group

Experimental group

Description:

Patients will receive bilateral ultrasound-guided cervical erector spinae plane block using 15 ml of bupivacaine 0.25% on each side.

Treatment:

Other: Cervical erector spinae plane block

SCPB group

Active Comparator group

Description:

Patients will receive bilateral ultrasound-guided superficial cervical block using 15 mL of 0.25% plain bupivacaine on each side of the neck.

Treatment:

Other: Cervical plexus block